Clinical trial
Study of Tumor RNA Disruption Assay™ (RDA)
NCT02239315
Study timeline
Study start (unknown)2015-12-01Date precision: month
Registry last updated2017-10-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Interventions
Sponsors & collaborators
University of Torontolead sponsor
University Health Network, Torontocollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02239315 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.